Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer
Both HER2 and ESR1 are determinant of KN026 efficacy in advanced HER2-positive breast cancer, implying the potential of KN026 combined with endocrine therapy in HER2- and ER-pos...